Autopsy report · NCT04431544

AcQMap® US Registry of Procedural and Long-term Clinical Outcomes (Discover-US)

“Sponsor no longer performing clinical studies. Will only be a manufacturer”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• Ran for about 3 years 1 month before it stopped.
• 513 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Acutus Medical

Sponsor type

Industry

Conditions

Ablation of Arrhythmia's

Interventions

AcQMap System

Participants

513

Sites

25

Countries

United States

Trials that died the same way

• Duet TRS Used in Pulmonary Resections
  “Sponsor is no longer pursuing this study” (80% match in meaning)
• Intravenous Ketamine Effects on Functional Neuroanatomy
  “Sponsor is no longer interested in funding the study” (76% match in meaning)
• KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
  “Study discontinued due to sponsor decision.” (74% match in meaning)
• Pembrolizumab Plus Lenvatinib in Previously Treated Classic Kaposi Sarcoma
  “The lack of adequate funding has made it impossible to continue with the clinical study As this study was not initiated, no subject was included and no data was collected,thus no result can be obtained SPONSOR\_DECISION End of trial date:15 Oct 2025” (74% match in meaning)
• Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera
  “The study was terminated by the sponsor” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.